179 related articles for article (PubMed ID: 20435175)
1. An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.
Califf RM; Lokhnygina Y; Cannon CP; Stepanavage ME; McCabe CH; Musliner TA; Pasternak RC; Blazing MA; Giugliano RP; Harrington RA; Braunwald E
Am Heart J; 2010 May; 159(5):705-9. PubMed ID: 20435175
[No Abstract] [Full Text] [Related]
2. In brief: Zetia and Vytorin: the ENHANCE study.
Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
[No Abstract] [Full Text] [Related]
3. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.
Blazing MA; Giugliano RP; Cannon CP; Musliner TA; Tershakovec AM; White JA; Reist C; McCagg A; Braunwald E; Califf RM
Am Heart J; 2014 Aug; 168(2):205-12.e1. PubMed ID: 25066560
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe plus simvastatin cardiovascular outcomes study program.
Padial LR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):17-25. PubMed ID: 18095904
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.
Pauriah M; Struthers AD; Lang CC
Cardiovasc Ther; 2008; 26(2):85-8. PubMed ID: 18485130
[No Abstract] [Full Text] [Related]
6. Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT.
Jarcho JA; Keaney JF
N Engl J Med; 2015 Jun; 372(25):2448-50. PubMed ID: 26039520
[No Abstract] [Full Text] [Related]
7. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
[No Abstract] [Full Text] [Related]
8. Dyslipidaemia: No limit to the benefits of LDL-cholesterol lowering.
Lim GB
Nat Rev Cardiol; 2015 Aug; 12(8):444. PubMed ID: 26099842
[No Abstract] [Full Text] [Related]
9. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Singh JS; Struthers AD; Lang CC
N Engl J Med; 2015 Oct; 373(15):1476. PubMed ID: 26444741
[No Abstract] [Full Text] [Related]
10. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Richard T; Lelubre C; Vanhaeverbeek M
N Engl J Med; 2015 Oct; 373(15):1475-6. PubMed ID: 26444740
[No Abstract] [Full Text] [Related]
11. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Nunes JP
N Engl J Med; 2015 Oct; 373(15):1475. PubMed ID: 26444739
[No Abstract] [Full Text] [Related]
12. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Patti G; Cavallari I
N Engl J Med; 2015 Oct; 373(15):1474-5. PubMed ID: 26444738
[No Abstract] [Full Text] [Related]
13. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Egom EE
N Engl J Med; 2015 Oct; 373(15):1474. PubMed ID: 26444737
[No Abstract] [Full Text] [Related]
14. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Couture P; Durand M; Laskine M
N Engl J Med; 2015 Oct; 373(15):1473-4. PubMed ID: 26444736
[No Abstract] [Full Text] [Related]
15. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Silbernagel G; Baumgartner I; März W
N Engl J Med; 2015 Oct; 373(15):1473. PubMed ID: 26444735
[No Abstract] [Full Text] [Related]
16. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Cannon CP; Blazing MA; Braunwald E
N Engl J Med; 2015 Oct; 373(15):1476-7. PubMed ID: 26444734
[No Abstract] [Full Text] [Related]
17. Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome.
Toth PP
Evid Based Med; 2015 Oct; 20(5):176. PubMed ID: 26261287
[No Abstract] [Full Text] [Related]
18. [Role of ezetimibe in secondary cardiovascular prevention finally determined?].
Lanzi D; Fumeaux T
Rev Med Suisse; 2015 Nov; 11(496):2257. PubMed ID: 26742360
[No Abstract] [Full Text] [Related]
19. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
20. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
